Data / Drug companies / Dimenhydrinate
Dimenhydrinate: 21 companies and 32 products in the FDA NDC directory
Dimenhydrinate is listed in the FDA National Drug Code Directory by 21 companies, with 32 products in commercial distribution. 1 of the products (3.1%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet; tablet, chewable; capsule, liquid filled, and the newest product started marketing on December 5, 2025.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 21
- Products
- 32
- Generic (ANDA) products
- 1 (3.1%)
- Application numbers
- 2
- Routes
- Oral, Intramuscular, Intravenous
- Brand names
- Motion Sickness Relief, Motion Sickness, Dramamine for Kids, Gravol, Airmit Ace, Driminate, Dramamine Original Formula, Dramamine Orange
- openFDA record search
- api.fda.gov
Companies that list dimenhydrinate
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Church & Dwight Co., Inc. | 5 | tablet, chewable; capsule, liquid filled | Over the counter monograph drugs | June 30, 2024 |
| Medtech Products Inc. | 5 | tablet, chewable; tablet | Over the counter monograph drugs | February 17, 2025 |
| Cardinal Health 110, LLC. DBA Leader | 2 | tablet | Over the counter monograph drugs | December 5, 2025 |
| Lil' Drug Store Products, Inc. | 2 | tablet, chewable | Over the counter monograph drugs | November 28, 2022 |
| Major Pharmaceuticals | 2 | tablet | Over the counter monograph drugs | February 14, 2019 |
| Amerisource Bergen | 1 | tablet | Over the counter monograph drugs | December 1, 1992 |
| CVS Pharmacy | 1 | tablet | Over the counter monograph drugs | December 1, 1992 |
| CVS Pharmacy | 1 | tablet | Over the counter monograph drugs | July 3, 2018 |
| Chain Drug Marketing Association, Inc. | 1 | tablet | Over the counter monograph drugs | April 4, 2024 |
| Fresenius Kabi USA, LLC | 1 | injection, solution | Generic drugs (ANDA) | November 29, 2004 |
| L.N.K. International, Inc. | 1 | tablet | Over the counter monograph drugs | December 1, 1992 |
| Perrigo Direct, Inc | 1 | tablet | Over the counter monograph drugs | April 7, 2020 |
| Rite Aid Corporation | 1 | tablet | Over the counter monograph drugs | December 1, 1992 |
| Sato Pharmaceutical Co., Ltd. | 1 | tablet | Over the counter monograph drugs | March 11, 2005 |
| Strategic Sourcing Services LLC | 1 | tablet | Over the counter monograph drugs | May 4, 2023 |
| Target Corporation | 1 | tablet | Over the counter monograph drugs | December 1, 1992 |
| Topco Associates LLC | 1 | tablet | Over the counter monograph drugs | December 1, 1992 |
| Valu Merchandisers Company | 1 | tablet | Over the counter monograph drugs | February 15, 2019 |
| Wal-Mart Stores Inc | 1 | tablet | Over the counter monograph drugs | December 1, 1992 |
| Walgreen Company | 1 | tablet | Over the counter monograph drugs | October 22, 2021 |
| WinCo Foods, LLC | 1 | tablet | Over the counter monograph drugs | December 1, 1992 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 20 | 62.5% |
| Tablet, chewable | 8 | 25% |
| Capsule, liquid filled | 1 | 3.1% |
| Syrup | 1 | 3.1% |
| Injection, solution | 1 | 3.1% |
| Tablet, coated | 1 | 3.1% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 31 | 96.9% |
| Generic drugs (ANDA) | 1 | 3.1% |
Pharmacologic classes
| Class | Products |
|---|---|
| Histamine-1 Receptor Antagonist | 24 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.